Literature DB >> 8066037

Comparison of first-trimester transvaginal amniocentesis with chorionic villus sampling and mid-trimester amniocentesis.

E Shalev1, E Weiner, N Yanai, Y Shneur, H Cohen.   

Abstract

Between August 1989 and December 1991, 356 patients underwent first-trimester transvaginal amniocentesis (10-12 weeks). The same number of patients referred in the same period for mid-trimester amniocentesis (14-21 weeks) was matched also for maternal age and indication. A third group consisted of the first 356 cases in which chorionic villus sampling (CVS) was attempted. The overall success rate was 99.7 and 100 per cent for early and mid-trimester amniocentesis, respectively, and 97.2 per cent for CVS. The mean harvesting time was 12.8, 11, and 7.9 days, respectively. The percentage of patients rescheduled was 3.4 per cent in first-trimester amniocentesis, 1.7 per cent in mid-trimester amniocentesis, and 6.2 per cent in the CVS group. The early (less than 2 weeks) pregnancy loss was 1.7 and 0.6 per cent in early and mid-trimester amniocentesis, respectively, and 1.7 per cent in CVS. The total pregnancy loss was 3.2, 0.9, and 2.9 per cent, respectively. The rate of preterm birth was 6.0, 5.2 and 6.9 per cent, respectively. The results indicate that CVS has the shortest procedure-result interval, but the highest rescheduling rate. First-trimester amniocentesis has a higher procedure and laboratory success rate but, until otherwise proved, mid-trimester amniocentesis is the most efficient and safest procedure.

Entities:  

Mesh:

Year:  1994        PMID: 8066037     DOI: 10.1002/pd.1970140407

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  2 in total

Review 1.  Amniocentesis and chorionic villus sampling for prenatal diagnosis.

Authors:  Zarko Alfirevic; Kate Navaratnam; Faris Mujezinovic
Journal:  Cochrane Database Syst Rev       Date:  2017-09-04

Review 2.  Amniocentesis and chorionic villus sampling for prenatal diagnosis.

Authors:  Z Alfirevic; K Sundberg; S Brigham
Journal:  Cochrane Database Syst Rev       Date:  2003
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.